1. Iacobuzio-Donahue, C.A., Velculescu, V.E., Wolfgang, C.L., and Hruban, R.H. (2012). Genetic basis of pancreas cancer development and progres- sion: insights from whole-exome and whole-genome sequencing. Clin. Cancer Res. 18, 4257–4265.
2. Hruban, R.H., Takaori, K., Klimstra, D.S., Adsay, N.V., Albores-Saavedra, J., Biankin, A.V., Biankin, S.A., Compton, C., Fukushima, N., Furukawa, T., et al. (2004). An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am. J. Surg. Pathol. 28, 977–987.
3. Hingorani, S.R., Wang, L., Multani, A.S., Combs, C., Deramaudt, T.B., Hruban, R.H., Rustgi, A.K., Chang, S., and Tuveson, D.A. (2005). Trp53R172H and KrasG12D cooperate to promote chromosomal insta- bility and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469–483.
4. Casasent, A.K., Edgerton, M., and Navin, N.E. (2017). Genome evolution in ductal carcinoma in situ: invasion of the clones. J. Pathol. 241, 208–218.
5. Burstein, H.J., Polyak, K., Wong, J.S., Lester, S.C., and Kaelin, C.M. (2004). Ductal carcinoma in situ of the breast. N. Engl. J. Med. 350, 1430–1441.
6. Temin, H.M. (1960). The control of cellular morphology in embryonic cells infected with rous sarcoma virus in vitro. Virology 10, 182–197.
7. Abercrombie, M. (1970). Contact inhibition in tissue culture. In Vitro 6, 128–142.
8. Haigis, K.M., Kendall, K.R., Wang, Y., Cheung, A., Haigis, M.C., Glickman, J.N., Niwa-Kawakita, M., Sweet-Cordero, A., Sebolt-Leopold, J., Shannon, K.M., et al. (2008). Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat. Genet. 40, 600–608.
9. Merrick, D.T., Kittelson, J., Winterhalder, R., Kotantoulas, G., Ingeberg, S., Keith, R.L., Kennedy, T.C., Miller, Y.E., Franklin, W.A., and Hirsch, F.R. (2006). Analysis of c-ErbB1/epidermal growth factor receptor and c- ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer. Clin. Cancer Res. 12, 2281– 2288.
10. Cordero, J.B., Ridgway, R.A., Valeri, N., Nixon, C., Frame, M.C., Muller, W.J., Vidal, M., and Sansom, O.J. (2014). c-Src drives intestinal regener- ation and transformation. EMBO J. 33, 1474–1491.
11. Frisch, S.M., and Screaton, R.A. (2001). Anoikis mechanisms. Curr. Opin. Cell Biol. 13, 555–562.
12. Schafer, Z.T., Grassian, A.R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H.Y., Gao, S., Puigserver, P., and Brugge, J.S. (2009). Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attach- ment. Nature 461, 109–113.
13. Frisch, S.M., and Francis, H. (1994). Disruption of epithelial cell-matrix in- teractions induces apoptosis. J. Cell Biol. 124, 619–626.
14. Martin, T.A., Harrison, G., Mansel, R.E., and Jiang, W.G. (2003). The role of the CD44/ezrin complex in cancer metastasis. Crit. Rev. Oncol. Hematol. 46, 165–186.
15. Senbanjo, L.T., and Chellaiah, M.A. (2017). CD44: a multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells. Front. Cell Dev. Biol. 5, 18.
16. Auvinen, P., Tammi, R., Tammi, M., Johansson, R., and Kosma, V.M. (2005). Expression of CD 44 s, CD 44 v 3 and CD 44 v 6 in benign and ma- lignant breast lesions: correlation and colocalization with hyaluronan. Histopathology 47, 420–428.
17. Ba` nkfalvi, A., Terpe, H.J., Breukelmann, D., Bier, B., Rempe, D., Pschadka, G., Krech, R., Lelle` , R.J., and Boecker, W. (1999). Immunophenotypic and prognostic analysis of E-cadherin and beta-cate- nin expression during breast carcinogenesis and tumour progression: a comparative study with CD44. Histopathology 34, 25–34.
18. Oda, Y., Aishima, S., Morimatsu, K., Hayashi, A., Shindo, K., Fujino, M., Mizuuchi, Y., Hattori, M., Tanaka, M., and Oda, Y. (2013). Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intrae- pithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas. Hum. Pathol. 44, 1487–1498.
19. Kalantari, E., Asgari, M., Nikpanah, S., Salarieh, N., Asadi Lari, M.H., and Madjd, Z. (2017). Co-expression of putative cancer stem cell markers CD44 and CD133 in prostate carcinomas. Pathol. Oncol. Res. 23, 793–802.
20. Morrison, H., Sherman, L.S., Legg, J., Banine, F., Isacke, C., Haipek, C.A., Gutmann, D.H., Ponta, H., and Herrlich, P. (2001). The NF2 tumor suppres- sor gene product, merlin, mediates contact inhibition of growth through in- teractions with CD44. Genes Dev. 15, 968–980.
21. Natsuga, K., Watanabe, M., Nishie, W., and Shimizu, H. (2019). Life before and beyond blistering: The role of collagen XVII in epidermal physiology. Exp. Dermatol. 28, 1135–1141.
22. Owens, D.W., McLean, G.W., Wyke, A.W., Paraskeva, C., Parkinson, E.K., Frame, M.C., and Brunton, V.G. (2000). The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell con- tacts. Mol. Biol. Cell 11, 51–64.
23. Huber, B.E., and Cordingley, M.G. (1988). Expression and phenotypic al- terations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells. Oncogene 3, 245–256.
24. Lindsay, J., Jiao, X., Sakamaki, T., Casimiro, M.C., Shirley, L.A., Tran, T.H., Ju, X., Liu, M., Li, Z., Wang, C., et al. (2008). ErbB2 induces Notch1 activity and function in breast cancer cells. Clin. Transl. Sci. 1, 107–115.
25. Marinari, E., Mehonic, A., Curran, S., Gale, J., Duke, T., and Baum, B. (2012). Live-cell delamination counterbalances epithelial growth to limit tissue overcrowding. Nature 484, 542–545.
26. Eisenhoffer, G.T., Loftus, P.D., Yoshigi, M., Otsuna, H., Chien, C.B., Morcos, P.A., and Rosenblatt, J. (2012). Crowding induces live cell extru- sion to maintain homeostatic cell numbers in epithelia. Nature 484, 546–549.
27. Makohon-Moore, A., and Iacobuzio-Donahue, C.A. (2016). Pancreatic cancer biology and genetics from an evolutionary perspective. Nat. Rev. Cancer 16, 553–565.
28. Brown, C.W., Amante, J.J., Goel, H.L., and Mercurio, A.M. (2017). The a6b4 integrin promotes resistance to ferroptosis. J. Cell Biol. 216, 4287– 4297.
29. Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., Patel, D.N., Bauer, A.J., Cantley, A.M., Yang, W.S., et al. (2012). Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060–1072.
30. Kleppner, S.R., and Tobin, A.J. (2002). GABA. In Encyclopedia of the Human Brain, First Edition, V.S. Ramachandran, ed. (Elsevier), pp. 353–367.
31. Chouchani, E.T., Pell, V.R., Gaude, E., Aksentijevic´, D., Sundier, S.Y., Robb, E.L., Logan, A., Nadtochiy, S.M., Ord, E.N.J., Smith, A.C., et al. (2014). Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515, 431–435.
32. Mills, E.L., Kelly, B., Logan, A., Costa, A.S.H., Varma, M., Bryant, C.E., Tourlomousis, P., Da€britz, J.H.M., Gottlieb, E., Latorre, I., et al. (2016). Succinate dehydrogenase supports metabolic repurposing of mitochon- dria to drive inflammatory macrophages. Cell 167, 457–470.e13.
33. Hofmann, M., Rudy, W., Gu¨ nthert, U., Zimmer, S.G., Zawadzki, V., Zo¨ ller, M., Lichtner, R.B., Herrlich, P., and Ponta, H. (1993). A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activ- ity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res. 53, 1516–1521.
34. Jamal, H.H., Cano-Gauci, D.F., Buick, R.N., and Filmus, J. (1994). Activated ras and src induce CD44 overexpression in rat intestinal epithe- lial cells. Oncogene 9, 417–423.
35. Zhao, B., Wei, X., Li, W., Udan, R.S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007). Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747–2761.
36. Levayer, R., Dupont, C., and Moreno, E. (2016). Tissue crowding induces caspase-dependent competition for space. Curr. Biol. 26, 670–677.
37. Moreno, E., Valon, L., Levillayer, F., and Levayer, R. (2019). Competition for space induces cell elimination through compaction-driven ERK down- regulation. Curr. Biol. 29, 23–34.e8.
38. Hogan, C., Dupre´-Crochet, S., Norman, M., Kajita, M., Zimmermann, C., Pelling, A.E., Piddini, E., Baena-Lo´ pez, L.A., Vincent, J.P., Itoh, Y., et al. (2009). Characterization of the interface between normal and transformed epithelial cells. Nat. Cell Biol. 11, 460–467.
39. Kon, S., Ishibashi, K., Katoh, H., Kitamoto, S., Shirai, T., Tanaka, S., Kajita, M., Ishikawa, S., Yamauchi, H., Yako, Y., et al. (2017). Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes. Nat. Cell Biol. 19, 530–541.
40. Sasaki, A., Nagatake, T., Egami, R., Gu, G., Takigawa, I., Ikeda, W., Nakatani, T., Kunisawa, J., and Fujita, Y. (2018). Obesity suppresses cell-competition-mediated apical elimination of RasV12-transformed cells from epithelial tissues. Cell Rep. 23, 974–982.
41. Kajita, M., Sugimura, K., Ohoka, A., Burden, J., Suganuma, H., Ikegawa, M., Shimada, T., Kitamura, T., Shindoh, M., Ishikawa, S., et al. (2014). Filamin acts as a key regulator in epithelial defence against transformed cells. Nat. Commun. 5, 4428.
42. Porazinski, S., de Navascue´s, J., Yako, Y., Hill, W., Jones, M.R., Maddison, R., Fujita, Y., and Hogan, C. (2016). EphA2 drives the segrega- tion of Ras-transformed epithelial cells from normal neighbors. Curr. Biol. 26, 3220–3229.
43. Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., et al. (2011). CD44 variant reg- ulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 19, 387–400.
44. Waters, A.M., and Der, C.J. (2018). KRAS: the critical driver and therapeu- tic target for pancreatic cancer. Cold Spring Harb. Perspect. Med. 8, a031435.
45. Vincent, A., Herman, J., Schulick, R., Hruban, R.H., and Goggins, M. (2011). Pancreatic cancer. Lancet 378, 607–620.
46. Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C.D., Biankin, A.V., Neale, R.E., Tempero, M., Tuveson, D.A., Hruban, R.H., and Neoptolemos, J.P. (2016). Pancreatic cancer. Nat. Rev. Dis. Primers 2, 16022.
47. Rhim, A.D., Mirek, E.T., Aiello, N.M., Maitra, A., Bailey, J.M., McAllister, F., Reichert, M., Beatty, G.L., Rustgi, A.K., Vonderheide, R.H., et al. (2012). EMT and dissemination precede pancreatic tumor formation. Cell 148, 349–361.
48. Maruyama, T., Dougan, S.K., Truttmann, M.C., Bilate, A.M., Ingram, J.R., and Ploegh, H.L. (2016). Corrigendum: increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat. Biotechnol. 34, 210.
49. Ohoka, A., Kajita, M., Ikenouchi, J., Yako, Y., Kitamoto, S., Kon, S., Ikegawa, M., Shimada, T., Ishikawa, S., and Fujita, Y. (2015). EPLIN is a crucial regulator for extrusion of RasV12-transformed cells. J. Cell Sci. 128, 781–789.
50. Hsu, P.D., Scott, D.A., Weinstein, J.A., Ran, F.A., Konermann, S., Agarwala, V., Li, Y., Fine, E.J., Wu, X., Shalem, O., et al. (2013). DNA tar- geting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827–832.
51. Kajita, M., Hogan, C., Harris, A.R., Dupre-Crochet, S., Itasaki, N., Kawakami, K., Charras, G., Tada, M., and Fujita, Y. (2010). Interaction with surrounding normal epithelial cells influences signalling pathways and behaviour of Src-transformed cells. J. Cell Sci. 123, 171–180.
52. Hogan, C., Serpente, N., Cogram, P., Hosking, C.R., Bialucha, C.U., Feller, S.M., Braga, V.M., Birchmeier, W., and Fujita, Y. (2004). Rap1 regulates the formation of E-cadherin-based cell-cell contacts. Mol. Cell. Biol. 24, 6690–6700.
53. Marks, J.D., and Bradbury, A. (2004). Selection of human antibodies from phage display libraries. Methods Mol. Biol. 248, 161–176.
54. Naruse, K., Yamada, T., Sai, X.R., Hamaguchi, M., and Sokabe, M. (1998). Pp125FAK is required for stretch dependent morphological response of endothelial cells. Oncogene 17, 455–463.
55. Satoh, K., Yachida, S., Sugimoto, M., Oshima, M., Nakagawa, T., Akamoto, S., Tabata, S., Saitoh, K., Kato, K., Sato, S., et al. (2017). Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC. Proc. Natl. Acad. Sci. USA 114, E7697– E7706.
56. Soga, T., Baran, R., Suematsu, M., Ueno, Y., Ikeda, S., Sakurakawa, T., Kakazu, Y., Ishikawa, T., Robert, M., Nishioka, T., and Tomita, M. (2006). Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J. Biol. Chem. 281, 16768–16776.
57. Soga, T., Igarashi, K., Ito, C., Mizobuchi, K., Zimmermann, H.P., and Tomita, M. (2009). Metabolomic profiling of anionic metabolites by capil- lary electrophoresis mass spectrometry. Anal. Chem. 81, 6165–6174.
58. Yang, M., Soga, T., and Pollard, P.J. (2013). Oncometabolites: linking altered metabolism with cancer. J. Clin. Invest. 123, 3652–3658.
59. Isokawa, M., Funatsu, T., and Tsunoda, M. (2013). Fast and simultaneous analysis of biothiols by high-performance liquid chromatography with fluo- rescence detection under hydrophilic interaction chromatography condi- tions. Analyst (Lond.) 138, 3802–3808.